Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Link

Showing results (161-170 of 303) with videos related to

Pageof 31
Sort By:
The American Journal of Cardiology|April 17, 2020
Meta-analysis of Usefulness of Phrenic Nerve Stimulation in Central Sleep ApneaFaraz Khan Luni, James Daniels, Mark S Link, et al.
The American Journal of Cardiology|July 12, 2020
Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic CardiomyopathyEthan J Rowin, Aadhavi Sridharan, Christopher Madias, et al.
JACC. Clinical Electrophysiology|August 22, 2020
Evidence That Subcutaneous Implantable Cardioverter-Defibrillators Are Effective and Reliable in Hypertrophic CardiomyopathyMartin S Maron, Nathaniel Steiger, Austin Burrows, et al.
Heart Rhythm O2|July 30, 2025
Case series of black athletes participating in sports with an implantable cardioverter-defibrillator: Data from the ICD Sports RegistryMerije T Chukumerije, Brian Olshansky, Elizabeth V Saarel, et al.
Journal of the American College of Cardiology|February 18, 2017
Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and ManagementEthan J Rowin, Barry J Maron, Tammy S Haas, et al.
Circulation. Arrhythmia and Electrophysiology|September 8, 2020
Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator ImplantsEthan J Rowin, Austin Burrows, Christopher Madias, et al.
Circulation. Arrhythmia and Electrophysiology|February 3, 2025
Global and Temporal Trends in Utilization and Outcomes of Implantable Cardioverter Defibrillators in Hypertrophic CardiomyopathyOmar M Abdelfattah, Ahmed Sayed, Ahmed Al-Jwaid, et al.
Journal of the American College of Cardiology|June 18, 2013
Acute exposure to air pollution triggers atrial fibrillationMark S Link, Heike Luttmann-Gibson, Joel Schwartz, et al.
Journal of the American College of Cardiology|November 26, 2013
Reply: Triggering of cardiac arrhythmias: the problem of multicollinearity among air pollution and meteorological factorsMark S Link, Heike Luttmann-Gibson, Joel Schwartz, et al.
The American Journal of Cardiology|May 21, 2005
Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathyMartin S Maron, Andrey G Zenovich, Susan A Casey, et al.
Pageof 31

Showing results (161-170 of 303) with videos related to

Sort By:
Pageof 31
The American Journal of Cardiology|April 17, 2020
Meta-analysis of Usefulness of Phrenic Nerve Stimulation in Central Sleep ApneaFaraz Khan Luni, James Daniels, Mark S Link, et al.
The American Journal of Cardiology|July 12, 2020
Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic CardiomyopathyEthan J Rowin, Aadhavi Sridharan, Christopher Madias, et al.
JACC. Clinical Electrophysiology|August 22, 2020
Evidence That Subcutaneous Implantable Cardioverter-Defibrillators Are Effective and Reliable in Hypertrophic CardiomyopathyMartin S Maron, Nathaniel Steiger, Austin Burrows, et al.
Heart Rhythm O2|July 30, 2025
Case series of black athletes participating in sports with an implantable cardioverter-defibrillator: Data from the ICD Sports RegistryMerije T Chukumerije, Brian Olshansky, Elizabeth V Saarel, et al.
Journal of the American College of Cardiology|February 18, 2017
Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and ManagementEthan J Rowin, Barry J Maron, Tammy S Haas, et al.
Circulation. Arrhythmia and Electrophysiology|September 8, 2020
Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator ImplantsEthan J Rowin, Austin Burrows, Christopher Madias, et al.
Circulation. Arrhythmia and Electrophysiology|February 3, 2025
Global and Temporal Trends in Utilization and Outcomes of Implantable Cardioverter Defibrillators in Hypertrophic CardiomyopathyOmar M Abdelfattah, Ahmed Sayed, Ahmed Al-Jwaid, et al.
Journal of the American College of Cardiology|June 18, 2013
Acute exposure to air pollution triggers atrial fibrillationMark S Link, Heike Luttmann-Gibson, Joel Schwartz, et al.
Journal of the American College of Cardiology|November 26, 2013
Reply: Triggering of cardiac arrhythmias: the problem of multicollinearity among air pollution and meteorological factorsMark S Link, Heike Luttmann-Gibson, Joel Schwartz, et al.
The American Journal of Cardiology|May 21, 2005
Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathyMartin S Maron, Andrey G Zenovich, Susan A Casey, et al.
Pageof 31